Certificate in Trial Participant Screening Protocols
-- ViewingNowThe Certificate in Trial Participant Screening Protocols is a comprehensive course designed to meet the growing industry demand for experts in clinical trial participant screening. This course emphasizes the importance of thorough participant screening, a critical aspect of successful clinical trials, by providing learners with in-depth knowledge of screening protocols and best practices.
7,382+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ๅ ณไบ่ฟ้จ่ฏพ็จ
100%ๅจ็บฟ
้ๆถ้ๅฐๅญฆไน
ๅฏๅไบซ็่ฏไนฆ
ๆทปๅ ๅฐๆจ็LinkedInไธชไบบ่ตๆ
2ไธชๆๅฎๆ
ๆฏๅจ2-3ๅฐๆถ
้ๆถๅผๅง
ๆ ็ญๅพ ๆ
่ฏพ็จ่ฏฆๆ
โข Introduction to Trial Participant Screening Protocols: Understanding the importance of screening protocols in clinical trials, including eligibility criteria, exclusion criteria, and the role of informed consent.
โข Pre-Screening Procedures: Learning about the initial steps in the screening process, such as reviewing medical histories, conducting interviews, and identifying potential participants.
โข Screening Evaluations: Exploring the various assessments used during the screening process, including physical examinations, laboratory tests, and imaging studies.
โข Data Management in Screening: Understanding the importance of accurate data collection and management during the screening process, including data entry, security, and confidentiality.
โข Ethical Considerations in Trial Participant Screening: Examining the ethical issues surrounding the screening process, such as informed consent, patient privacy, and the potential for bias.
โข Regulatory Compliance in Screening: Learning about the regulatory requirements for clinical trial screening protocols, including FDA regulations, ICH guidelines, and local laws.
โข Screening Process Improvement: Exploring strategies for improving the screening process, including the use of technology, standardization, and quality control measures.
โข Communication and Documentation in Screening: Understanding the importance of clear communication and documentation during the screening process, including with study sponsors, investigators, and participants.
่ไธ้่ทฏ
ๅ ฅๅญฆ่ฆๆฑ
- ๅฏนไธป้ข็ๅบๆฌ็่งฃ
- ่ฑ่ฏญ่ฏญ่จ่ฝๅ
- ่ฎก็ฎๆบๅไบ่็ฝ่ฎฟ้ฎ
- ๅบๆฌ่ฎก็ฎๆบๆ่ฝ
- ๅฎๆ่ฏพ็จ็ๅฅ็ฎ็ฒพ็ฅ
ๆ ้ไบๅ ็ๆญฃๅผ่ตๆ ผใ่ฏพ็จ่ฎพ่ฎกๆณจ้ๅฏ่ฎฟ้ฎๆงใ
่ฏพ็จ็ถๆ
ๆฌ่ฏพ็จไธบ่ไธๅๅฑๆไพๅฎ็จ็็ฅ่ฏๅๆ่ฝใๅฎๆฏ๏ผ
- ๆช็ป่ฎคๅฏๆบๆ่ฎค่ฏ
- ๆช็ปๆๆๆบๆ็็ฎก
- ๅฏนๆญฃๅผ่ตๆ ผ็่กฅๅ
ๆๅๅฎๆ่ฏพ็จๅ๏ผๆจๅฐ่ทๅพ็ปไธ่ฏไนฆใ
ไธบไปไนไบบไปฌ้ๆฉๆไปฌไฝไธบ่ไธๅๅฑ
ๆญฃๅจๅ ่ฝฝ่ฏ่ฎบ...
ๅธธ่ง้ฎ้ข
่ฏพ็จ่ดน็จ
- ๆฏๅจ3-4ๅฐๆถ
- ๆๅ่ฏไนฆไบคไป
- ๅผๆพๆณจๅ - ้ๆถๅผๅง
- ๆฏๅจ2-3ๅฐๆถ
- ๅธธ่ง่ฏไนฆไบคไป
- ๅผๆพๆณจๅ - ้ๆถๅผๅง
- ๅฎๆด่ฏพ็จ่ฎฟ้ฎ
- ๆฐๅญ่ฏไนฆ
- ่ฏพ็จๆๆ
่ทๅ่ฏพ็จไฟกๆฏ
่ทๅพ่ไธ่ฏไนฆ
